Trachoma: Clinical Trials

4 trials for Trachoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Withdrawn 1
Phase 21Withdrawn 1

Follow Trachoma: new trials by email Literature Review of Trachoma trials Research Report on Trachoma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
Albendazole on Day 1, Ivermectin on Day 1, Diethylcarbamazine on day 1 - Trachoma, Yaws
Phase 3CompletedLihir Medical Centre200002018-10-012019-02-28
Sanitation, Water, and Instruction in Face-washing for Trachoma I/II
Water, sanitation, and hygiene (WASH) intervention, Standard of care WASH intervention, Azithromycin - Trachoma
Phase 3CompletedUniversity of California, San Francisco476052015-12-052026-06-04
Nepal Elimination of Trachoma Study
Azithromycin - Trachoma
Phase 2 / Phase 3WithdrawnUniversity of California, San Francisco2014-08-012015-05-21
Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma
Azithromycin - Trachoma
Phase 3CompletedLaboratoires Thea2004-01-012006-07-26

Narrower conditions

Elephantiasis, Filarial (1)  ·  Neglected Diseases (1)  ·  Scabies (1)  ·  Strongyloidiasis (1)  ·  Yaws (1)

Broader conditions

Bacterial Infections (4)  ·  Bacterial Infections and Mycoses (4)  ·  Chlamydia Infections (4)  ·  Chlamydiaceae Infections (4)  ·  Conjunctival Diseases (4)  ·  Conjunctivitis (4)  ·  Conjunctivitis, Bacterial (4)  ·  Corneal Diseases (4)  ·  Eye Diseases (4)  ·  Eye Infections (4)  ·  Eye Infections, Bacterial (4)  ·  Gram-Negative Bacterial Infections (4)  ·  Infections (4)  ·  Disease Attributes (1)  ·  Ectoparasitic Infestations (1)

Interventions

Azithromycin (4)  ·  Albendazole (1)  ·  Diethylcarbamazine (1)  ·  Health (1)  ·  Hygiene (1)  ·  Ivermectin (1)  ·  Methods (1)  ·  Sanitation (1)  ·  Tetracycline (1)  ·  Therapeutic Irrigation (1)  ·  Water (1)

Sponsors

University of California, San Francisco (2)  ·  Laboratoires Thea (1)  ·  Lihir Medical Centre (1)

Countries

Ethiopia (1)  ·  Nepal (1)  ·  Papua New Guinea (1)

Top investigators

Bruce D Gaynor, MD (1)  ·  Dionna M Wittberg, MPH (1)  ·  Jeremy D Keenan, MD, MPH (1)  ·  Lucy John, MD (1)  ·  Zerihun Tadese, MD, MPH (1)

Results publications

PMID 33619183, PMID 34919861, PMID 38134305, PMID 38991011, PMID 41314021, PMID 41548574

NIH funding

K23EY019881 (1), U10EY023939 (1)